171 related articles for article (PubMed ID: 38423011)
21. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.
Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881
[TBL] [Abstract][Full Text] [Related]
22. Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.
Moreira D; Sampath S; Won H; White SV; Su YL; Alcantara M; Wang C; Lee P; Maghami E; Massarelli E; Kortylewski M
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33232304
[TBL] [Abstract][Full Text] [Related]
23. Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
Wu L; Mao L; Liu JF; Chen L; Yu GT; Yang LL; Wu H; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Cancer Immunol Res; 2019 Oct; 7(10):1700-1713. PubMed ID: 31387897
[TBL] [Abstract][Full Text] [Related]
24. Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma.
Hartman DJ; Ahmad F; Ferris RL; Rimm DL; Pantanowitz L
Oral Oncol; 2018 Nov; 86():278-287. PubMed ID: 30409313
[TBL] [Abstract][Full Text] [Related]
25. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
[TBL] [Abstract][Full Text] [Related]
26.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
27. EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy.
Kumai T; Matsuda Y; Oikawa K; Aoki N; Kimura S; Harabuchi Y; Celis E; Kobayashi H
Br J Cancer; 2013 Oct; 109(8):2155-66. PubMed ID: 24045666
[TBL] [Abstract][Full Text] [Related]
28. Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC.
Gong X; Xiong J; Gong Y; Zhang J; Zhang J; Yang G; Chi H; Tian G
Front Immunol; 2023; 14():1275270. PubMed ID: 37876923
[TBL] [Abstract][Full Text] [Related]
29. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy.
Starska-Kowarska K
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980527
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
31. Esophageal squamous cell carcinoma metachronous to head and neck cancers.
Businello G; Fassan M; Degasperi S; Traverso G; Scarpa M; Angriman I; Kotsafti A; Castagliuolo I; Sbaraglia M; Bardini R; Scarpa M
Pathol Res Pract; 2021 Mar; 219():153346. PubMed ID: 33545655
[TBL] [Abstract][Full Text] [Related]
32. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
33. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.
Wood O; Woo J; Seumois G; Savelyeva N; McCann KJ; Singh D; Jones T; Peel L; Breen MS; Ward M; Garrido Martin E; Sanchez-Elsner T; Thomas G; Vijayanand P; Woelk CH; King E; Ottensmeier C;
Oncotarget; 2016 Aug; 7(35):56781-56797. PubMed ID: 27462861
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
35. Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck.
Zandberg DP; Menk AV; Velez M; Normolle D; DePeaux K; Liu A; Ferris RL; Delgoffe GM
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986123
[TBL] [Abstract][Full Text] [Related]
36. Specific knockout of Notch2 in Treg cells significantly inhibits the growth and proliferation of head and neck squamous cell carcinoma in mice.
Wei JH; Qiao YL; Xu S; Zou Y; Ni HF; Wu LZ; Tao ZZ; Jiao WE; Chen SM
Int Immunopharmacol; 2023 Oct; 123():110705. PubMed ID: 37523971
[TBL] [Abstract][Full Text] [Related]
37. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas.
Sánchez-Canteli M; Juesas L; Garmendia I; Otero-Rosales M; Calvo A; Alvarez-Fernández M; Astudillo A; Montuenga LM; García-Pedrero JM; Rodrigo JP
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232859
[TBL] [Abstract][Full Text] [Related]
38. Fewer tumour-specific PD-1
Xu K; Fu Y; Han Y; Xia R; Xu S; Duan S; Zhang Z; Li J
Br J Cancer; 2020 Sep; 123(6):932-941. PubMed ID: 32616847
[TBL] [Abstract][Full Text] [Related]
39. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
[TBL] [Abstract][Full Text] [Related]
40. IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models.
Yu J; Gadwa J; Ross RB; Knitz M; Darragh LB; Abdelazeem KNM; Beynor J; Neupert B; Nguyen A; Nguyen D; Olimpo N; Corbo S; Van Court B; D'Alessandro A; Saviola A; Karam SD
Cancer Immunol Immunother; 2024 Mar; 73(5):90. PubMed ID: 38554147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]